nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2D6—Temsirolimus—kidney cancer	0.077	0.131	CbGbCtD
Bicalutamide—CYP3A4—Everolimus—kidney cancer	0.0725	0.124	CbGbCtD
Bicalutamide—CYP3A4—Temsirolimus—kidney cancer	0.049	0.0835	CbGbCtD
Bicalutamide—CYP2C9—Capecitabine—kidney cancer	0.0461	0.0787	CbGbCtD
Bicalutamide—CYP2D6—Pazopanib—kidney cancer	0.0405	0.069	CbGbCtD
Bicalutamide—CYP2C19—Sorafenib—kidney cancer	0.0309	0.0526	CbGbCtD
Bicalutamide—CYP2C9—Paclitaxel—kidney cancer	0.0289	0.0493	CbGbCtD
Bicalutamide—CYP2D6—Erlotinib—kidney cancer	0.0289	0.0492	CbGbCtD
Bicalutamide—CYP3A4—Pazopanib—kidney cancer	0.0257	0.0439	CbGbCtD
Bicalutamide—CYP2C9—Sorafenib—kidney cancer	0.0257	0.0438	CbGbCtD
Bicalutamide—CYP2D6—Sorafenib—kidney cancer	0.0235	0.04	CbGbCtD
Bicalutamide—CYP2D6—Vinblastine—kidney cancer	0.0232	0.0395	CbGbCtD
Bicalutamide—CYP3A4—Erlotinib—kidney cancer	0.0184	0.0313	CbGbCtD
Bicalutamide—CYP3A4—Paclitaxel—kidney cancer	0.0168	0.0287	CbGbCtD
Bicalutamide—CYP3A4—Sorafenib—kidney cancer	0.0149	0.0255	CbGbCtD
Bicalutamide—CYP3A4—Vinblastine—kidney cancer	0.0147	0.0251	CbGbCtD
Bicalutamide—CYP3A4—Vincristine—kidney cancer	0.0145	0.0247	CbGbCtD
Bicalutamide—CYP2D6—Doxorubicin—kidney cancer	0.0142	0.0243	CbGbCtD
Bicalutamide—CYP3A4—Sunitinib—kidney cancer	0.0121	0.0206	CbGbCtD
Bicalutamide—CYP3A4—Doxorubicin—kidney cancer	0.00906	0.0154	CbGbCtD
Bicalutamide—CYP2C19—urine—kidney cancer	0.00327	0.21	CbGeAlD
Bicalutamide—CYP2C9—urine—kidney cancer	0.00254	0.163	CbGeAlD
Bicalutamide—CYP3A4—urine—kidney cancer	0.00194	0.124	CbGeAlD
Bicalutamide—CYP2D6—urine—kidney cancer	0.0019	0.122	CbGeAlD
Bicalutamide—Enzalutamide—ABCB1—kidney cancer	0.00102	1	CrCbGaD
Bicalutamide—AR—renal system—kidney cancer	0.000864	0.0556	CbGeAlD
Bicalutamide—AR—kidney—kidney cancer	0.000836	0.0537	CbGeAlD
Bicalutamide—AR—cortex of kidney—kidney cancer	0.000814	0.0523	CbGeAlD
Bicalutamide—AR—gonad—kidney cancer	0.000775	0.0498	CbGeAlD
Bicalutamide—AR—cardiac atrium—kidney cancer	0.000774	0.0498	CbGeAlD
Bicalutamide—CYP3A4—renal system—kidney cancer	0.000473	0.0304	CbGeAlD
Bicalutamide—CYP2D6—renal system—kidney cancer	0.000466	0.0299	CbGeAlD
Bicalutamide—CYP3A4—kidney—kidney cancer	0.000458	0.0294	CbGeAlD
Bicalutamide—CYP2D6—kidney—kidney cancer	0.00045	0.0289	CbGeAlD
Bicalutamide—Dyspnoea—Gemcitabine—kidney cancer	0.000137	0.000371	CcSEcCtD
Bicalutamide—Nausea—Vinblastine—kidney cancer	0.000137	0.000371	CcSEcCtD
Bicalutamide—Somnolence—Gemcitabine—kidney cancer	0.000137	0.00037	CcSEcCtD
Bicalutamide—Nausea—Everolimus—kidney cancer	0.000137	0.000369	CcSEcCtD
Bicalutamide—Diarrhoea—Sorafenib—kidney cancer	0.000137	0.000369	CcSEcCtD
Bicalutamide—Hypertension—Paclitaxel—kidney cancer	0.000136	0.000369	CcSEcCtD
Bicalutamide—Pruritus—Sunitinib—kidney cancer	0.000136	0.000367	CcSEcCtD
Bicalutamide—Angiopathy—Capecitabine—kidney cancer	0.000135	0.000365	CcSEcCtD
Bicalutamide—Immune system disorder—Capecitabine—kidney cancer	0.000135	0.000364	CcSEcCtD
Bicalutamide—Chest pain—Paclitaxel—kidney cancer	0.000135	0.000364	CcSEcCtD
Bicalutamide—Myalgia—Paclitaxel—kidney cancer	0.000135	0.000364	CcSEcCtD
Bicalutamide—Mediastinal disorder—Capecitabine—kidney cancer	0.000134	0.000363	CcSEcCtD
Bicalutamide—Anxiety—Paclitaxel—kidney cancer	0.000134	0.000363	CcSEcCtD
Bicalutamide—Face oedema—Doxorubicin—kidney cancer	0.000134	0.000362	CcSEcCtD
Bicalutamide—Decreased appetite—Gemcitabine—kidney cancer	0.000134	0.000362	CcSEcCtD
Bicalutamide—Hypersensitivity—Dactinomycin—kidney cancer	0.000134	0.000362	CcSEcCtD
Bicalutamide—Chills—Capecitabine—kidney cancer	0.000134	0.000361	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000134	0.000361	CcSEcCtD
Bicalutamide—Arrhythmia—Capecitabine—kidney cancer	0.000133	0.00036	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000133	0.00036	CcSEcCtD
Bicalutamide—Fatigue—Gemcitabine—kidney cancer	0.000133	0.000359	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Vincristine—kidney cancer	0.000133	0.000359	CcSEcCtD
Bicalutamide—Cardiac arrest—Doxorubicin—kidney cancer	0.000132	0.000357	CcSEcCtD
Bicalutamide—Dizziness—Sorafenib—kidney cancer	0.000132	0.000357	CcSEcCtD
Bicalutamide—Constipation—Gemcitabine—kidney cancer	0.000132	0.000356	CcSEcCtD
Bicalutamide—Pain—Gemcitabine—kidney cancer	0.000132	0.000356	CcSEcCtD
Bicalutamide—Nausea—Erlotinib—kidney cancer	0.000132	0.000356	CcSEcCtD
Bicalutamide—Alopecia—Capecitabine—kidney cancer	0.000132	0.000356	CcSEcCtD
Bicalutamide—Dry mouth—Paclitaxel—kidney cancer	0.000132	0.000356	CcSEcCtD
Bicalutamide—Diarrhoea—Sunitinib—kidney cancer	0.000131	0.000355	CcSEcCtD
Bicalutamide—Mental disorder—Capecitabine—kidney cancer	0.000131	0.000353	CcSEcCtD
Bicalutamide—Asthenia—Dactinomycin—kidney cancer	0.00013	0.000353	CcSEcCtD
Bicalutamide—Confusional state—Paclitaxel—kidney cancer	0.00013	0.000352	CcSEcCtD
Bicalutamide—Blood creatinine increased—Doxorubicin—kidney cancer	0.00013	0.000352	CcSEcCtD
Bicalutamide—Malnutrition—Capecitabine—kidney cancer	0.00013	0.000351	CcSEcCtD
Bicalutamide—Dehydration—Doxorubicin—kidney cancer	0.000129	0.000349	CcSEcCtD
Bicalutamide—Oedema—Paclitaxel—kidney cancer	0.000129	0.000349	CcSEcCtD
Bicalutamide—Abdominal pain—Vincristine—kidney cancer	0.000128	0.000347	CcSEcCtD
Bicalutamide—Body temperature increased—Vincristine—kidney cancer	0.000128	0.000347	CcSEcCtD
Bicalutamide—Liver function test abnormal—Doxorubicin—kidney cancer	0.000128	0.000347	CcSEcCtD
Bicalutamide—Infection—Paclitaxel—kidney cancer	0.000128	0.000346	CcSEcCtD
Bicalutamide—Flatulence—Capecitabine—kidney cancer	0.000128	0.000346	CcSEcCtD
Bicalutamide—Dry skin—Doxorubicin—kidney cancer	0.000127	0.000344	CcSEcCtD
Bicalutamide—Dizziness—Sunitinib—kidney cancer	0.000127	0.000343	CcSEcCtD
Bicalutamide—Feeling abnormal—Gemcitabine—kidney cancer	0.000127	0.000343	CcSEcCtD
Bicalutamide—Shock—Paclitaxel—kidney cancer	0.000127	0.000343	CcSEcCtD
Bicalutamide—Vomiting—Sorafenib—kidney cancer	0.000127	0.000343	CcSEcCtD
Bicalutamide—Nervous system disorder—Paclitaxel—kidney cancer	0.000126	0.000342	CcSEcCtD
Bicalutamide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000126	0.000341	CcSEcCtD
Bicalutamide—Rash—Sorafenib—kidney cancer	0.000126	0.00034	CcSEcCtD
Bicalutamide—Dermatitis—Sorafenib—kidney cancer	0.000126	0.00034	CcSEcCtD
Bicalutamide—Back pain—Capecitabine—kidney cancer	0.000125	0.000339	CcSEcCtD
Bicalutamide—Breast disorder—Doxorubicin—kidney cancer	0.000125	0.000339	CcSEcCtD
Bicalutamide—Skin disorder—Paclitaxel—kidney cancer	0.000125	0.000339	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000125	0.000338	CcSEcCtD
Bicalutamide—Headache—Sorafenib—kidney cancer	0.000125	0.000338	CcSEcCtD
Bicalutamide—Muscle spasms—Capecitabine—kidney cancer	0.000125	0.000337	CcSEcCtD
Bicalutamide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000125	0.000337	CcSEcCtD
Bicalutamide—Diarrhoea—Dactinomycin—kidney cancer	0.000124	0.000336	CcSEcCtD
Bicalutamide—Anorexia—Paclitaxel—kidney cancer	0.000123	0.000332	CcSEcCtD
Bicalutamide—Gastritis—Doxorubicin—kidney cancer	0.000123	0.000332	CcSEcCtD
Bicalutamide—Muscular weakness—Doxorubicin—kidney cancer	0.000122	0.000331	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000122	0.000331	CcSEcCtD
Bicalutamide—Vomiting—Sunitinib—kidney cancer	0.000122	0.00033	CcSEcCtD
Bicalutamide—Body temperature increased—Gemcitabine—kidney cancer	0.000122	0.000329	CcSEcCtD
Bicalutamide—Rash—Sunitinib—kidney cancer	0.000121	0.000327	CcSEcCtD
Bicalutamide—Dermatitis—Sunitinib—kidney cancer	0.000121	0.000327	CcSEcCtD
Bicalutamide—Headache—Sunitinib—kidney cancer	0.00012	0.000325	CcSEcCtD
Bicalutamide—Influenza—Doxorubicin—kidney cancer	0.00012	0.000324	CcSEcCtD
Bicalutamide—Asthma—Doxorubicin—kidney cancer	0.00012	0.000324	CcSEcCtD
Bicalutamide—Dysphagia—Doxorubicin—kidney cancer	0.00012	0.000324	CcSEcCtD
Bicalutamide—Anaemia—Capecitabine—kidney cancer	0.00012	0.000324	CcSEcCtD
Bicalutamide—Hypersensitivity—Vincristine—kidney cancer	0.00012	0.000323	CcSEcCtD
Bicalutamide—Eosinophilia—Doxorubicin—kidney cancer	0.000119	0.000321	CcSEcCtD
Bicalutamide—Nausea—Sorafenib—kidney cancer	0.000119	0.00032	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000118	0.000318	CcSEcCtD
Bicalutamide—Angina pectoris—Doxorubicin—kidney cancer	0.000117	0.000316	CcSEcCtD
Bicalutamide—Insomnia—Paclitaxel—kidney cancer	0.000117	0.000315	CcSEcCtD
Bicalutamide—Asthenia—Vincristine—kidney cancer	0.000117	0.000315	CcSEcCtD
Bicalutamide—Syncope—Capecitabine—kidney cancer	0.000116	0.000314	CcSEcCtD
Bicalutamide—Paraesthesia—Paclitaxel—kidney cancer	0.000116	0.000313	CcSEcCtD
Bicalutamide—Vomiting—Dactinomycin—kidney cancer	0.000116	0.000312	CcSEcCtD
Bicalutamide—Bronchitis—Doxorubicin—kidney cancer	0.000115	0.000312	CcSEcCtD
Bicalutamide—Dyspnoea—Paclitaxel—kidney cancer	0.000115	0.000311	CcSEcCtD
Bicalutamide—Somnolence—Paclitaxel—kidney cancer	0.000115	0.00031	CcSEcCtD
Bicalutamide—Rash—Dactinomycin—kidney cancer	0.000115	0.00031	CcSEcCtD
Bicalutamide—Nausea—Sunitinib—kidney cancer	0.000114	0.000308	CcSEcCtD
Bicalutamide—Loss of consciousness—Capecitabine—kidney cancer	0.000114	0.000308	CcSEcCtD
Bicalutamide—Dyspepsia—Paclitaxel—kidney cancer	0.000114	0.000307	CcSEcCtD
Bicalutamide—Cough—Capecitabine—kidney cancer	0.000113	0.000306	CcSEcCtD
Bicalutamide—Dysuria—Doxorubicin—kidney cancer	0.000112	0.000303	CcSEcCtD
Bicalutamide—Neutropenia—Doxorubicin—kidney cancer	0.000112	0.000303	CcSEcCtD
Bicalutamide—Decreased appetite—Paclitaxel—kidney cancer	0.000112	0.000303	CcSEcCtD
Bicalutamide—Hypertension—Capecitabine—kidney cancer	0.000112	0.000303	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000111	0.000301	CcSEcCtD
Bicalutamide—Fatigue—Paclitaxel—kidney cancer	0.000111	0.000301	CcSEcCtD
Bicalutamide—Diarrhoea—Vincristine—kidney cancer	0.000111	0.0003	CcSEcCtD
Bicalutamide—Pollakiuria—Doxorubicin—kidney cancer	0.000111	0.0003	CcSEcCtD
Bicalutamide—Asthenia—Gemcitabine—kidney cancer	0.000111	0.000299	CcSEcCtD
Bicalutamide—Chest pain—Capecitabine—kidney cancer	0.00011	0.000299	CcSEcCtD
Bicalutamide—Myalgia—Capecitabine—kidney cancer	0.00011	0.000299	CcSEcCtD
Bicalutamide—Constipation—Paclitaxel—kidney cancer	0.00011	0.000298	CcSEcCtD
Bicalutamide—Pain—Paclitaxel—kidney cancer	0.00011	0.000298	CcSEcCtD
Bicalutamide—Anxiety—Capecitabine—kidney cancer	0.00011	0.000297	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00011	0.000296	CcSEcCtD
Bicalutamide—Weight increased—Doxorubicin—kidney cancer	0.000109	0.000295	CcSEcCtD
Bicalutamide—Pruritus—Gemcitabine—kidney cancer	0.000109	0.000295	CcSEcCtD
Bicalutamide—Weight decreased—Doxorubicin—kidney cancer	0.000109	0.000293	CcSEcCtD
Bicalutamide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000108	0.000293	CcSEcCtD
Bicalutamide—Dry mouth—Capecitabine—kidney cancer	0.000108	0.000292	CcSEcCtD
Bicalutamide—Nausea—Dactinomycin—kidney cancer	0.000108	0.000292	CcSEcCtD
Bicalutamide—Pneumonia—Doxorubicin—kidney cancer	0.000108	0.000291	CcSEcCtD
Bicalutamide—Dizziness—Vincristine—kidney cancer	0.000107	0.00029	CcSEcCtD
Bicalutamide—Confusional state—Capecitabine—kidney cancer	0.000107	0.000289	CcSEcCtD
Bicalutamide—Feeling abnormal—Paclitaxel—kidney cancer	0.000106	0.000287	CcSEcCtD
Bicalutamide—Oedema—Capecitabine—kidney cancer	0.000106	0.000286	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000105	0.000285	CcSEcCtD
Bicalutamide—Diarrhoea—Gemcitabine—kidney cancer	0.000105	0.000285	CcSEcCtD
Bicalutamide—Infection—Capecitabine—kidney cancer	0.000105	0.000284	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000105	0.000284	CcSEcCtD
Bicalutamide—Jaundice—Doxorubicin—kidney cancer	0.000104	0.000282	CcSEcCtD
Bicalutamide—Shock—Capecitabine—kidney cancer	0.000104	0.000282	CcSEcCtD
Bicalutamide—Urinary tract infection—Doxorubicin—kidney cancer	0.000104	0.000281	CcSEcCtD
Bicalutamide—Conjunctivitis—Doxorubicin—kidney cancer	0.000104	0.000281	CcSEcCtD
Bicalutamide—Nervous system disorder—Capecitabine—kidney cancer	0.000104	0.000281	CcSEcCtD
Bicalutamide—Thrombocytopenia—Capecitabine—kidney cancer	0.000104	0.00028	CcSEcCtD
Bicalutamide—Vomiting—Vincristine—kidney cancer	0.000103	0.000279	CcSEcCtD
Bicalutamide—Skin disorder—Capecitabine—kidney cancer	0.000103	0.000278	CcSEcCtD
Bicalutamide—Sweating—Doxorubicin—kidney cancer	0.000103	0.000277	CcSEcCtD
Bicalutamide—Urticaria—Paclitaxel—kidney cancer	0.000102	0.000277	CcSEcCtD
Bicalutamide—Rash—Vincristine—kidney cancer	0.000102	0.000277	CcSEcCtD
Bicalutamide—Hyperhidrosis—Capecitabine—kidney cancer	0.000102	0.000277	CcSEcCtD
Bicalutamide—Dermatitis—Vincristine—kidney cancer	0.000102	0.000277	CcSEcCtD
Bicalutamide—Haematuria—Doxorubicin—kidney cancer	0.000102	0.000276	CcSEcCtD
Bicalutamide—Abdominal pain—Paclitaxel—kidney cancer	0.000102	0.000276	CcSEcCtD
Bicalutamide—Body temperature increased—Paclitaxel—kidney cancer	0.000102	0.000276	CcSEcCtD
Bicalutamide—Headache—Vincristine—kidney cancer	0.000102	0.000275	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000101	0.000274	CcSEcCtD
Bicalutamide—Epistaxis—Doxorubicin—kidney cancer	0.000101	0.000273	CcSEcCtD
Bicalutamide—Anorexia—Capecitabine—kidney cancer	0.000101	0.000273	CcSEcCtD
Bicalutamide—Sinusitis—Doxorubicin—kidney cancer	0.0001	0.000271	CcSEcCtD
Bicalutamide—Vomiting—Gemcitabine—kidney cancer	9.8e-05	0.000265	CcSEcCtD
Bicalutamide—Bradycardia—Doxorubicin—kidney cancer	9.78e-05	0.000264	CcSEcCtD
Bicalutamide—Rash—Gemcitabine—kidney cancer	9.71e-05	0.000263	CcSEcCtD
Bicalutamide—Dermatitis—Gemcitabine—kidney cancer	9.71e-05	0.000262	CcSEcCtD
Bicalutamide—Haemoglobin—Doxorubicin—kidney cancer	9.65e-05	0.000261	CcSEcCtD
Bicalutamide—Headache—Gemcitabine—kidney cancer	9.65e-05	0.000261	CcSEcCtD
Bicalutamide—Nausea—Vincristine—kidney cancer	9.65e-05	0.000261	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.64e-05	0.000261	CcSEcCtD
Bicalutamide—Rhinitis—Doxorubicin—kidney cancer	9.63e-05	0.00026	CcSEcCtD
Bicalutamide—Haemorrhage—Doxorubicin—kidney cancer	9.6e-05	0.00026	CcSEcCtD
Bicalutamide—Insomnia—Capecitabine—kidney cancer	9.57e-05	0.000259	CcSEcCtD
Bicalutamide—Pharyngitis—Doxorubicin—kidney cancer	9.53e-05	0.000258	CcSEcCtD
Bicalutamide—Paraesthesia—Capecitabine—kidney cancer	9.51e-05	0.000257	CcSEcCtD
Bicalutamide—Hypersensitivity—Paclitaxel—kidney cancer	9.5e-05	0.000257	CcSEcCtD
Bicalutamide—Urinary tract disorder—Doxorubicin—kidney cancer	9.48e-05	0.000256	CcSEcCtD
Bicalutamide—Oedema peripheral—Doxorubicin—kidney cancer	9.46e-05	0.000256	CcSEcCtD
Bicalutamide—Dyspnoea—Capecitabine—kidney cancer	9.44e-05	0.000255	CcSEcCtD
Bicalutamide—Urethral disorder—Doxorubicin—kidney cancer	9.41e-05	0.000255	CcSEcCtD
Bicalutamide—Dyspepsia—Capecitabine—kidney cancer	9.32e-05	0.000252	CcSEcCtD
Bicalutamide—Visual impairment—Doxorubicin—kidney cancer	9.26e-05	0.00025	CcSEcCtD
Bicalutamide—Asthenia—Paclitaxel—kidney cancer	9.25e-05	0.00025	CcSEcCtD
Bicalutamide—Decreased appetite—Capecitabine—kidney cancer	9.2e-05	0.000249	CcSEcCtD
Bicalutamide—Nausea—Gemcitabine—kidney cancer	9.15e-05	0.000247	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Capecitabine—kidney cancer	9.14e-05	0.000247	CcSEcCtD
Bicalutamide—Fatigue—Capecitabine—kidney cancer	9.13e-05	0.000247	CcSEcCtD
Bicalutamide—Pruritus—Paclitaxel—kidney cancer	9.13e-05	0.000247	CcSEcCtD
Bicalutamide—Pain—Capecitabine—kidney cancer	9.05e-05	0.000245	CcSEcCtD
Bicalutamide—Constipation—Capecitabine—kidney cancer	9.05e-05	0.000245	CcSEcCtD
Bicalutamide—Cardiac disorder—Doxorubicin—kidney cancer	8.91e-05	0.000241	CcSEcCtD
Bicalutamide—Diarrhoea—Paclitaxel—kidney cancer	8.83e-05	0.000239	CcSEcCtD
Bicalutamide—Feeling abnormal—Capecitabine—kidney cancer	8.72e-05	0.000236	CcSEcCtD
Bicalutamide—Angiopathy—Doxorubicin—kidney cancer	8.71e-05	0.000236	CcSEcCtD
Bicalutamide—Immune system disorder—Doxorubicin—kidney cancer	8.68e-05	0.000235	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Capecitabine—kidney cancer	8.66e-05	0.000234	CcSEcCtD
Bicalutamide—Mediastinal disorder—Doxorubicin—kidney cancer	8.66e-05	0.000234	CcSEcCtD
Bicalutamide—Chills—Doxorubicin—kidney cancer	8.62e-05	0.000233	CcSEcCtD
Bicalutamide—Arrhythmia—Doxorubicin—kidney cancer	8.58e-05	0.000232	CcSEcCtD
Bicalutamide—Dizziness—Paclitaxel—kidney cancer	8.53e-05	0.000231	CcSEcCtD
Bicalutamide—Alopecia—Doxorubicin—kidney cancer	8.49e-05	0.000229	CcSEcCtD
Bicalutamide—Mental disorder—Doxorubicin—kidney cancer	8.41e-05	0.000227	CcSEcCtD
Bicalutamide—Urticaria—Capecitabine—kidney cancer	8.41e-05	0.000227	CcSEcCtD
Bicalutamide—Abdominal pain—Capecitabine—kidney cancer	8.37e-05	0.000226	CcSEcCtD
Bicalutamide—Body temperature increased—Capecitabine—kidney cancer	8.37e-05	0.000226	CcSEcCtD
Bicalutamide—Malnutrition—Doxorubicin—kidney cancer	8.36e-05	0.000226	CcSEcCtD
Bicalutamide—Flatulence—Doxorubicin—kidney cancer	8.24e-05	0.000223	CcSEcCtD
Bicalutamide—Tension—Doxorubicin—kidney cancer	8.2e-05	0.000222	CcSEcCtD
Bicalutamide—Vomiting—Paclitaxel—kidney cancer	8.2e-05	0.000222	CcSEcCtD
Bicalutamide—Rash—Paclitaxel—kidney cancer	8.13e-05	0.00022	CcSEcCtD
Bicalutamide—Dermatitis—Paclitaxel—kidney cancer	8.13e-05	0.00022	CcSEcCtD
Bicalutamide—Nervousness—Doxorubicin—kidney cancer	8.12e-05	0.00022	CcSEcCtD
Bicalutamide—Back pain—Doxorubicin—kidney cancer	8.09e-05	0.000219	CcSEcCtD
Bicalutamide—Headache—Paclitaxel—kidney cancer	8.08e-05	0.000218	CcSEcCtD
Bicalutamide—Muscle spasms—Doxorubicin—kidney cancer	8.04e-05	0.000217	CcSEcCtD
Bicalutamide—Hypersensitivity—Capecitabine—kidney cancer	7.8e-05	0.000211	CcSEcCtD
Bicalutamide—Anaemia—Doxorubicin—kidney cancer	7.73e-05	0.000209	CcSEcCtD
Bicalutamide—Nausea—Paclitaxel—kidney cancer	7.66e-05	0.000207	CcSEcCtD
Bicalutamide—Asthenia—Capecitabine—kidney cancer	7.59e-05	0.000205	CcSEcCtD
Bicalutamide—Syncope—Doxorubicin—kidney cancer	7.5e-05	0.000203	CcSEcCtD
Bicalutamide—Pruritus—Capecitabine—kidney cancer	7.49e-05	0.000202	CcSEcCtD
Bicalutamide—Loss of consciousness—Doxorubicin—kidney cancer	7.35e-05	0.000199	CcSEcCtD
Bicalutamide—Cough—Doxorubicin—kidney cancer	7.3e-05	0.000197	CcSEcCtD
Bicalutamide—Diarrhoea—Capecitabine—kidney cancer	7.24e-05	0.000196	CcSEcCtD
Bicalutamide—Hypertension—Doxorubicin—kidney cancer	7.22e-05	0.000195	CcSEcCtD
Bicalutamide—Chest pain—Doxorubicin—kidney cancer	7.12e-05	0.000192	CcSEcCtD
Bicalutamide—Myalgia—Doxorubicin—kidney cancer	7.12e-05	0.000192	CcSEcCtD
Bicalutamide—Anxiety—Doxorubicin—kidney cancer	7.09e-05	0.000192	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.07e-05	0.000191	CcSEcCtD
Bicalutamide—Dizziness—Capecitabine—kidney cancer	7e-05	0.000189	CcSEcCtD
Bicalutamide—Dry mouth—Doxorubicin—kidney cancer	6.96e-05	0.000188	CcSEcCtD
Bicalutamide—Confusional state—Doxorubicin—kidney cancer	6.88e-05	0.000186	CcSEcCtD
Bicalutamide—Oedema—Doxorubicin—kidney cancer	6.82e-05	0.000184	CcSEcCtD
Bicalutamide—Infection—Doxorubicin—kidney cancer	6.78e-05	0.000183	CcSEcCtD
Bicalutamide—Vomiting—Capecitabine—kidney cancer	6.73e-05	0.000182	CcSEcCtD
Bicalutamide—Shock—Doxorubicin—kidney cancer	6.71e-05	0.000181	CcSEcCtD
Bicalutamide—Nervous system disorder—Doxorubicin—kidney cancer	6.69e-05	0.000181	CcSEcCtD
Bicalutamide—Thrombocytopenia—Doxorubicin—kidney cancer	6.68e-05	0.000181	CcSEcCtD
Bicalutamide—Rash—Capecitabine—kidney cancer	6.67e-05	0.00018	CcSEcCtD
Bicalutamide—Dermatitis—Capecitabine—kidney cancer	6.67e-05	0.00018	CcSEcCtD
Bicalutamide—Headache—Capecitabine—kidney cancer	6.63e-05	0.000179	CcSEcCtD
Bicalutamide—Skin disorder—Doxorubicin—kidney cancer	6.63e-05	0.000179	CcSEcCtD
Bicalutamide—Hyperhidrosis—Doxorubicin—kidney cancer	6.6e-05	0.000178	CcSEcCtD
Bicalutamide—Anorexia—Doxorubicin—kidney cancer	6.5e-05	0.000176	CcSEcCtD
Bicalutamide—Nausea—Capecitabine—kidney cancer	6.29e-05	0.00017	CcSEcCtD
Bicalutamide—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	6.26e-05	0.00231	CbGpPWpGaD
Bicalutamide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.22e-05	0.000168	CcSEcCtD
Bicalutamide—Insomnia—Doxorubicin—kidney cancer	6.17e-05	0.000167	CcSEcCtD
Bicalutamide—Paraesthesia—Doxorubicin—kidney cancer	6.13e-05	0.000166	CcSEcCtD
Bicalutamide—CYP2C19—Biological oxidations—GSTT1—kidney cancer	6.12e-05	0.00226	CbGpPWpGaD
Bicalutamide—Dyspnoea—Doxorubicin—kidney cancer	6.08e-05	0.000164	CcSEcCtD
Bicalutamide—Somnolence—Doxorubicin—kidney cancer	6.07e-05	0.000164	CcSEcCtD
Bicalutamide—Dyspepsia—Doxorubicin—kidney cancer	6.01e-05	0.000162	CcSEcCtD
Bicalutamide—Decreased appetite—Doxorubicin—kidney cancer	5.93e-05	0.00016	CcSEcCtD
Bicalutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—kidney cancer	5.91e-05	0.00218	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—MTOR—kidney cancer	5.9e-05	0.00217	CbGpPWpGaD
Bicalutamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.89e-05	0.000159	CcSEcCtD
Bicalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.89e-05	0.00217	CbGpPWpGaD
Bicalutamide—Fatigue—Doxorubicin—kidney cancer	5.88e-05	0.000159	CcSEcCtD
Bicalutamide—Pain—Doxorubicin—kidney cancer	5.84e-05	0.000158	CcSEcCtD
Bicalutamide—Constipation—Doxorubicin—kidney cancer	5.84e-05	0.000158	CcSEcCtD
Bicalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.83e-05	0.00215	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—PTGS1—kidney cancer	5.74e-05	0.00212	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTT1—kidney cancer	5.63e-05	0.00208	CbGpPWpGaD
Bicalutamide—Feeling abnormal—Doxorubicin—kidney cancer	5.62e-05	0.000152	CcSEcCtD
Bicalutamide—CYP2C9—Biological oxidations—GSTT1—kidney cancer	5.58e-05	0.00206	CbGpPWpGaD
Bicalutamide—Gastrointestinal pain—Doxorubicin—kidney cancer	5.58e-05	0.000151	CcSEcCtD
Bicalutamide—AR—Generic Transcription Pathway—JUNB—kidney cancer	5.52e-05	0.00204	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—EEF2—kidney cancer	5.49e-05	0.00202	CbGpPWpGaD
Bicalutamide—Urticaria—Doxorubicin—kidney cancer	5.42e-05	0.000147	CcSEcCtD
Bicalutamide—Body temperature increased—Doxorubicin—kidney cancer	5.39e-05	0.000146	CcSEcCtD
Bicalutamide—Abdominal pain—Doxorubicin—kidney cancer	5.39e-05	0.000146	CcSEcCtD
Bicalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	5.38e-05	0.00199	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CCND1—kidney cancer	5.28e-05	0.00195	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—PTGS1—kidney cancer	5.28e-05	0.00195	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—JUN—kidney cancer	5.27e-05	0.00194	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—TET2—kidney cancer	5.26e-05	0.00194	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—PTGS1—kidney cancer	5.23e-05	0.00193	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	5.23e-05	0.00193	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.19e-05	0.00191	CbGpPWpGaD
Bicalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	5.16e-05	0.0019	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—JUN—kidney cancer	5.13e-05	0.00189	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—PTEN—kidney cancer	5.09e-05	0.00188	CbGpPWpGaD
Bicalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	5.09e-05	0.00188	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	5.09e-05	0.00188	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	5.06e-05	0.00187	CbGpPWpGaD
Bicalutamide—Hypersensitivity—Doxorubicin—kidney cancer	5.03e-05	0.000136	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	5e-05	0.00185	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.95e-05	0.00183	CbGpPWpGaD
Bicalutamide—Asthenia—Doxorubicin—kidney cancer	4.9e-05	0.000132	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	4.84e-05	0.00179	CbGpPWpGaD
Bicalutamide—Pruritus—Doxorubicin—kidney cancer	4.83e-05	0.000131	CcSEcCtD
Bicalutamide—AR—Gene Expression—TCEB1—kidney cancer	4.81e-05	0.00177	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—TCEB2—kidney cancer	4.81e-05	0.00177	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.77e-05	0.00176	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.73e-05	0.00174	CbGpPWpGaD
Bicalutamide—Diarrhoea—Doxorubicin—kidney cancer	4.67e-05	0.000126	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.61e-05	0.0017	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	4.6e-05	0.0017	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.58e-05	0.00169	CbGpPWpGaD
Bicalutamide—Dizziness—Doxorubicin—kidney cancer	4.51e-05	0.000122	CcSEcCtD
Bicalutamide—AR—Generic Transcription Pathway—CDKN2B—kidney cancer	4.5e-05	0.00166	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—VEGFA—kidney cancer	4.48e-05	0.00165	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.37e-05	0.00161	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.36e-05	0.00161	CbGpPWpGaD
Bicalutamide—Vomiting—Doxorubicin—kidney cancer	4.34e-05	0.000117	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.33e-05	0.0016	CbGpPWpGaD
Bicalutamide—Rash—Doxorubicin—kidney cancer	4.3e-05	0.000116	CcSEcCtD
Bicalutamide—Dermatitis—Doxorubicin—kidney cancer	4.3e-05	0.000116	CcSEcCtD
Bicalutamide—Headache—Doxorubicin—kidney cancer	4.27e-05	0.000116	CcSEcCtD
Bicalutamide—CYP2C19—Biological oxidations—GSTP1—kidney cancer	4.24e-05	0.00156	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	4.23e-05	0.00156	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.22e-05	0.00156	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	4.18e-05	0.00154	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.18e-05	0.00154	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	4.14e-05	0.00153	CbGpPWpGaD
Bicalutamide—Nausea—Doxorubicin—kidney cancer	4.05e-05	0.00011	CcSEcCtD
Bicalutamide—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	3.91e-05	0.00144	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—RPL14—kidney cancer	3.91e-05	0.00144	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTP1—kidney cancer	3.9e-05	0.00144	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GSTM1—kidney cancer	3.9e-05	0.00144	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GSTP1—kidney cancer	3.87e-05	0.00143	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	3.85e-05	0.00142	CbGpPWpGaD
Bicalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.85e-05	0.00142	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	3.85e-05	0.00142	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	3.82e-05	0.00141	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.81e-05	0.00141	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	3.7e-05	0.00136	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.68e-05	0.00136	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	3.65e-05	0.00134	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.61e-05	0.00133	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTM1—kidney cancer	3.59e-05	0.00132	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GSTM1—kidney cancer	3.55e-05	0.00131	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	3.54e-05	0.0013	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.51e-05	0.00129	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	3.51e-05	0.00129	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	3.48e-05	0.00128	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.45e-05	0.00127	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.43e-05	0.00127	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	3.4e-05	0.00125	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	3.37e-05	0.00124	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	3.35e-05	0.00124	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	3.32e-05	0.00123	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ACY1—kidney cancer	3.25e-05	0.0012	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.24e-05	0.0012	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—EIF4EBP1—kidney cancer	3.19e-05	0.00118	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—HSPB1—kidney cancer	3.19e-05	0.00118	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.12e-05	0.00115	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ACY1—kidney cancer	2.99e-05	0.0011	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.98e-05	0.0011	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ACY1—kidney cancer	2.96e-05	0.00109	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PSMD7—kidney cancer	2.96e-05	0.00109	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.88e-05	0.00106	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.77e-05	0.00102	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PDHB—kidney cancer	2.76e-05	0.00102	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—POMC—kidney cancer	2.76e-05	0.00102	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—JUNB—kidney cancer	2.66e-05	0.000981	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CCBL1—kidney cancer	2.6e-05	0.000959	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.55e-05	0.000941	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PDHB—kidney cancer	2.54e-05	0.000938	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—POMC—kidney cancer	2.53e-05	0.000935	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.53e-05	0.000932	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PDHB—kidney cancer	2.52e-05	0.00093	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.52e-05	0.000928	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—POMC—kidney cancer	2.51e-05	0.000927	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CCBL1—kidney cancer	2.39e-05	0.000882	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CCBL1—kidney cancer	2.37e-05	0.000874	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.35e-05	0.000867	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.34e-05	0.000865	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.31e-05	0.000853	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPAT—kidney cancer	2.25e-05	0.000831	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.25e-05	0.000831	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.22e-05	0.000821	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.22e-05	0.00082	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.2e-05	0.000812	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.19e-05	0.000808	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—CDKN2B—kidney cancer	2.16e-05	0.000798	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.14e-05	0.00079	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APRT—kidney cancer	2.09e-05	0.000773	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—FH—kidney cancer	2.09e-05	0.000773	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPAT—kidney cancer	2.07e-05	0.000764	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.07e-05	0.000764	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.05e-05	0.000758	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPAT—kidney cancer	2.05e-05	0.000758	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.05e-05	0.000755	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.03e-05	0.000748	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.01e-05	0.000741	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GPC3—kidney cancer	1.97e-05	0.000726	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ACY1—kidney cancer	1.96e-05	0.000721	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APRT—kidney cancer	1.93e-05	0.000711	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—FH—kidney cancer	1.93e-05	0.000711	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CA2—kidney cancer	1.92e-05	0.000707	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APRT—kidney cancer	1.91e-05	0.000704	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—FH—kidney cancer	1.91e-05	0.000704	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALAD—kidney cancer	1.87e-05	0.000689	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.87e-05	0.000689	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.82e-05	0.000672	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GPC3—kidney cancer	1.81e-05	0.000668	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GPC3—kidney cancer	1.8e-05	0.000662	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.78e-05	0.000657	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CA2—kidney cancer	1.76e-05	0.00065	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CA2—kidney cancer	1.75e-05	0.000644	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—MYC—kidney cancer	1.74e-05	0.000643	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALAD—kidney cancer	1.72e-05	0.000633	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PGK1—kidney cancer	1.71e-05	0.00063	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.71e-05	0.00063	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALAD—kidney cancer	1.7e-05	0.000628	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.68e-05	0.000618	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LDHB—kidney cancer	1.67e-05	0.000618	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PDHB—kidney cancer	1.66e-05	0.000613	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.66e-05	0.000613	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—POMC—kidney cancer	1.66e-05	0.000611	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.64e-05	0.000604	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.62e-05	0.000599	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PGK1—kidney cancer	1.57e-05	0.000579	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.57e-05	0.000579	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CCBL1—kidney cancer	1.56e-05	0.000576	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PGK1—kidney cancer	1.56e-05	0.000574	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.56e-05	0.000574	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LDHB—kidney cancer	1.54e-05	0.000568	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LDHB—kidney cancer	1.53e-05	0.000563	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CA9—kidney cancer	1.45e-05	0.000536	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.42e-05	0.000523	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.36e-05	0.0005	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPAT—kidney cancer	1.36e-05	0.0005	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CA9—kidney cancer	1.34e-05	0.000493	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CA9—kidney cancer	1.32e-05	0.000488	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.29e-05	0.000477	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APRT—kidney cancer	1.26e-05	0.000465	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—FH—kidney cancer	1.26e-05	0.000465	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CRABP1—kidney cancer	1.23e-05	0.000455	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPC3—kidney cancer	1.18e-05	0.000437	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CA2—kidney cancer	1.15e-05	0.000425	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ITPR2—kidney cancer	1.15e-05	0.000423	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CRABP1—kidney cancer	1.14e-05	0.000419	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CRABP1—kidney cancer	1.13e-05	0.000415	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALAD—kidney cancer	1.12e-05	0.000414	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.1e-05	0.000404	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.07e-05	0.000395	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.06e-05	0.00039	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ITPR2—kidney cancer	1.06e-05	0.000389	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTT1—kidney cancer	1.05e-05	0.000386	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ACHE—kidney cancer	1.05e-05	0.000386	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ITPR2—kidney cancer	1.05e-05	0.000386	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.03e-05	0.000379	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PGK1—kidney cancer	1.03e-05	0.000379	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LDHB—kidney cancer	1.01e-05	0.000371	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SCARB1—kidney cancer	9.91e-06	0.000365	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS1—kidney cancer	9.81e-06	0.000362	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.65e-06	0.000356	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ACHE—kidney cancer	9.63e-06	0.000355	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTT1—kidney cancer	9.63e-06	0.000355	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PSMD7—kidney cancer	9.62e-06	0.000355	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTT1—kidney cancer	9.54e-06	0.000352	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ACHE—kidney cancer	9.54e-06	0.000352	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—BCHE—kidney cancer	9.12e-06	0.000336	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SCARB1—kidney cancer	9.11e-06	0.000336	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SCARB1—kidney cancer	9.03e-06	0.000333	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS1—kidney cancer	9.02e-06	0.000333	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC5A5—kidney cancer	9.01e-06	0.000332	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS1—kidney cancer	8.94e-06	0.00033	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PSMD7—kidney cancer	8.85e-06	0.000326	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PSMD7—kidney cancer	8.77e-06	0.000323	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CA9—kidney cancer	8.73e-06	0.000322	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC2A1—kidney cancer	8.7e-06	0.000321	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MAPK3—kidney cancer	8.63e-06	0.000318	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.44e-06	0.000311	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MYC—kidney cancer	8.39e-06	0.000309	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—BCHE—kidney cancer	8.39e-06	0.000309	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—BCHE—kidney cancer	8.31e-06	0.000307	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC5A5—kidney cancer	8.28e-06	0.000306	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC5A5—kidney cancer	8.21e-06	0.000303	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC2A1—kidney cancer	8e-06	0.000295	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC2A1—kidney cancer	7.93e-06	0.000293	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.7e-06	0.000284	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CRABP1—kidney cancer	7.42e-06	0.000274	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.36e-06	0.000271	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTP1—kidney cancer	7.26e-06	0.000268	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ITPR2—kidney cancer	6.9e-06	0.000255	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCB1—kidney cancer	6.87e-06	0.000253	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.71e-06	0.000248	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTP1—kidney cancer	6.67e-06	0.000246	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM1—kidney cancer	6.67e-06	0.000246	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTP1—kidney cancer	6.62e-06	0.000244	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP1A1—kidney cancer	6.32e-06	0.000233	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCB1—kidney cancer	6.32e-06	0.000233	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ACHE—kidney cancer	6.29e-06	0.000232	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTT1—kidney cancer	6.29e-06	0.000232	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCB1—kidney cancer	6.26e-06	0.000231	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM1—kidney cancer	6.13e-06	0.000226	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM1—kidney cancer	6.08e-06	0.000224	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SCARB1—kidney cancer	5.96e-06	0.00022	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS1—kidney cancer	5.9e-06	0.000218	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP1A1—kidney cancer	5.81e-06	0.000214	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PSMD7—kidney cancer	5.78e-06	0.000213	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.76e-06	0.000213	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—BCHE—kidney cancer	5.48e-06	0.000202	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.42e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.23e-06	0.000193	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.19e-06	0.000192	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.73e-06	0.000175	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—POMC—kidney cancer	4.71e-06	0.000174	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTP1—kidney cancer	4.36e-06	0.000161	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—POMC—kidney cancer	4.33e-06	0.00016	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—POMC—kidney cancer	4.3e-06	0.000158	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCB1—kidney cancer	4.13e-06	0.000152	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM1—kidney cancer	4.01e-06	0.000148	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.8e-06	0.00014	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—kidney cancer	3.76e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—kidney cancer	3.46e-06	0.000128	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—kidney cancer	3.43e-06	0.000126	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTEN—kidney cancer	3.28e-06	0.000121	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTEN—kidney cancer	3.02e-06	0.000111	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTEN—kidney cancer	2.99e-06	0.00011	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—POMC—kidney cancer	2.83e-06	0.000105	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.31e-06	8.53e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—kidney cancer	2.26e-06	8.34e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.13e-06	7.84e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.11e-06	7.78e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTEN—kidney cancer	1.97e-06	7.27e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.39e-06	5.13e-05	CbGpPWpGaD
